Clinical Trial Update: Real-world First-line Serplulimab-based Immunochemotherapy for Extensive-stage Small Cell Lung Cancer

View source ↗

Summary

Real-world update on first-line serplulimab-based immunochemotherapy for extensive-stage small cell lung cancer; the study is currently active but not recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Serplulimab (serplulimab)

Snippet

Sponsor: Hunan Cancer Hospital | Conditions: Extensive-stage Small Cell Lung Cancer (ES-SCLC) | Status: ACTIVE_NOT_RECRUITING